Detalles de la búsqueda
1.
Impact of multidisciplinary tumour board in the management of ovarian carcinoma in the first-line setting. Exhaustive analysis from the Rhone-Alpes region.
Eur J Cancer Care (Engl)
; 29(6): e13313, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32894629
2.
Being treated in higher volume hospitals leads to longer progression-free survival for epithelial ovarian carcinoma patients in the Rhone-Alpes region of France.
BMC Health Serv Res
; 18(1): 3, 2018 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29301572
3.
Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial.
BMC Cancer
; 12: 603, 2012 Dec 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-23244208
4.
Final results of ERASME-4: a randomized trial of first-line docetaxel plus either capecitabine or epirubicin for metastatic breast cancer.
Oncology
; 80(3-4): 262-8, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21734418
5.
Management of rare ovarian cancers: the experience of the French website "Observatory for rare malignant tumours of the ovaries" by the GINECO group: interim analysis of the first 100 patients.
Gynecol Oncol
; 119(1): 53-9, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20580063
Resultados
1 -
5
de 5
1
Próxima >
>>